Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 834

1.

Accuracy of endoscopic staging and targeted biopsies for routine gastric intestinal metaplasia and gastric atrophy evaluation study protocol of a prospective, cohort study: the estimate study.

Nieuwenburg SAV, Waddingham WW, Graham D, Rodriguez-Justo M, Biermann K, Kuipers EJ, Banks M, Jansen M, Spaander MCW.

BMJ Open. 2019 Sep 18;9(9):e032013. doi: 10.1136/bmjopen-2019-032013.

PMID:
31537576
2.

Incidence of Interval Colorectal Cancer After Negative Results From First-round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age.

Toes-Zoutendijk E, Kooyker AI, Dekker E, Spaander MCW, Opstal-van Winden AWJ, Ramakers C, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I; Dutch national colorectal cancer screening working group.

Clin Gastroenterol Hepatol. 2019 Aug 20. pii: S1542-3565(19)30896-1. doi: 10.1016/j.cgh.2019.08.021. [Epub ahead of print]

3.

Composition of the mucosa-associated microbiota along the entire gastrointestinal tract of human individuals.

Vuik F, Dicksved J, Lam SY, Fuhler GM, van der Laan L, van de Winkel A, Konstantinov SR, Spaander M, Peppelenbosch MP, Engstrand L, Kuipers EJ.

United European Gastroenterol J. 2019 Aug;7(7):897-907. doi: 10.1177/2050640619852255. Epub 2019 May 17.

4.

Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.

Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mallant-Hent RC, Lansdorp-Vogelaar I, Bossuyt PMM, Kuipers EJ, Dekker E, Spaander MCW.

Clin Gastroenterol Hepatol. 2019 Aug 13. pii: S1542-3565(19)30890-0. doi: 10.1016/j.cgh.2019.08.015. [Epub ahead of print]

PMID:
31419575
5.

British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.

Banks M, Graham D, Jansen M, Gotoda T, Coda S, di Pietro M, Uedo N, Bhandari P, Pritchard DM, Kuipers EJ, Rodriguez-Justo M, Novelli MR, Ragunath K, Shepherd N, Dinis-Ribeiro M.

Gut. 2019 Sep;68(9):1545-1575. doi: 10.1136/gutjnl-2018-318126. Epub 2019 Jul 5.

6.

Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.

Schreuders EH, Grobbee EJ, Nieuwenburg SAV, Kapidzic A, van Roon AHC, van Vuuren AJ, Lansdorp-Vogelaar I, Spijker WWJ, Izelaar K, Bruno MJ, Kuipers EJ, Spaander MCW.

Lancet Gastroenterol Hepatol. 2019 Aug;4(8):622-631. doi: 10.1016/S2468-1253(19)30176-1. Epub 2019 Jun 10.

PMID:
31196734
7.

Implications of different guidelines for surveillance after serrated polyp resection in United States of America and Europe.

Bleijenberg A, Klotz D, Løberg M, Dekker E, Adami HO, Kuipers EJ, Holme Ø, Kalager M, Emilsson L, Kleist B, Løvdal L, Regula J, Løberg EM, IJspeert J, Bretthauer M.

Endoscopy. 2019 Aug;51(8):750-758. doi: 10.1055/a-0916-8598. Epub 2019 Jun 13.

PMID:
31195423
8.

Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years.

Vuik FE, Nieuwenburg SA, Bardou M, Lansdorp-Vogelaar I, Dinis-Ribeiro M, Bento MJ, Zadnik V, Pellisé M, Esteban L, Kaminski MF, Suchanek S, Ngo O, Májek O, Leja M, Kuipers EJ, Spaander MC.

Gut. 2019 Oct;68(10):1820-1826. doi: 10.1136/gutjnl-2018-317592. Epub 2019 May 16.

9.

Effects of Oral Anticoagulant and Aspirin Use on Ability of Fecal Immunochemical Tests to Detect Advanced Neoplasia.

Spaander MCW, Kuipers EJ.

Gastroenterology. 2019 May;156(6):1553-1555. doi: 10.1053/j.gastro.2019.03.031. Epub 2019 Mar 26. No abstract available.

PMID:
30926342
10.

Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019.

Pimentel-Nunes P, Libânio D, Marcos-Pinto R, Areia M, Leja M, Esposito G, Garrido M, Kikuste I, Megraud F, Matysiak-Budnik T, Annibale B, Dumonceau JM, Barros R, Fléjou JF, Carneiro F, van Hooft JE, Kuipers EJ, Dinis-Ribeiro M.

Endoscopy. 2019 Apr;51(4):365-388. doi: 10.1055/a-0859-1883. Epub 2019 Mar 6.

11.

Participation and Ease of Use in Colorectal Cancer Screening: A Comparison of 2 Fecal Immunochemical Tests.

de Klerk CM, Wieten E, van der Steen A, Ramakers CR, Kuipers EJ, Hansen BE, Lansdorp-Vogelaar I, Bossuyt PM, Spaander MCW, Dekker E.

Am J Gastroenterol. 2019 Mar;114(3):511-518. doi: 10.14309/ajg.0000000000000148.

PMID:
30789417
12.

Quality Monitoring of a FIT-Based Colorectal Cancer Screening Program.

Toes-Zoutendijk E, Bonfrer JMG, Ramakers C, Thelen M, Spaander MCW, Dekker E, van der Meulen MP, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, van Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I.

Clin Chem. 2019 Mar;65(3):419-426. doi: 10.1373/clinchem.2018.294041. Epub 2019 Jan 16.

PMID:
30651228
13.

High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors.

Rigter LS, Spaander MCW, Aleman BMP, Bisseling TM, Moons LM, Cats A, Lugtenburg PJ, Janus CPM, Petersen EJ, Roesink JM, van der Maazen RWM, Snaebjornsson P, Kuipers EJ, Bruno MJ, Dekker E, Meijer GA, de Boer JP, van Leeuwen FE, van Leerdam ME.

Cancer. 2019 Mar 15;125(6):990-999. doi: 10.1002/cncr.31903. Epub 2018 Dec 18.

14.

Molecular profiling of longitudinally observed small colorectal polyps: A cohort study.

van Lanschot MCJ, Carvalho B, Rausch C, Snaebjornsson P, van Engeland M, Kuipers EJ, Stoker J, Tutein Nolthenius CJ, Dekker E, Meijer GA.

EBioMedicine. 2019 Jan;39:292-300. doi: 10.1016/j.ebiom.2018.12.009. Epub 2018 Dec 13.

15.

Percutaneous endoscopic gastrostomy in older patients with and without dementia: Survival and ethical considerations.

van Bruchem-Visser RL, Mattace-Raso FUS, de Beaufort ID, Kuipers EJ.

J Gastroenterol Hepatol. 2019 Apr;34(4):736-741. doi: 10.1111/jgh.14573. Epub 2019 Jan 8.

PMID:
30551264
16.

Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Mortality Collaborators.

Lancet. 2018 Nov 10;392(10159):1684-1735. doi: 10.1016/S0140-6736(18)31891-9. Epub 2018 Nov 8. Erratum in: Lancet. 2019 Jun 22;393(10190):e44.

17.

Patients with chronic mesenteric ischemia have an altered sublingual microcirculation.

Harki J, Suker M, Tovar-Doncel MS, van Dijk LJ, van Noord D, van Eijck CH, Bruno MJ, Kuipers EJ, Ince C.

Clin Exp Gastroenterol. 2018 Oct 18;11:405-414. doi: 10.2147/CEG.S159160. eCollection 2018.

18.

Diminutive Polyps With Advanced Histologic Features Do Not Increase Risk for Metachronous Advanced Colon Neoplasia.

Vleugels JLA, Hassan C, Senore C, Cassoni P, Baron JA, Rex DK, Ponugoti PL, Pellise M, Parejo S, Bessa X, Arnau-Collell C, Kaminski MF, Bugajski M, Wieszczy P, Kuipers EJ, Melson J, Ma KH, Holman R, Dekker E, Pohl H.

Gastroenterology. 2019 Feb;156(3):623-634.e3. doi: 10.1053/j.gastro.2018.10.050. Epub 2018 Nov 2.

PMID:
30395813
19.

Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.

Wieten E, de Klerk CM, van der Steen A, Ramakers CR, Kuipers EJ, Hansen BE, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MCW.

Gastroenterology. 2018 Nov;155(5):1392-1399.e5. doi: 10.1053/j.gastro.2018.07.021. Epub 2018 Jul 25.

PMID:
30055170
20.

Detection of mesenteric ischemia by means of endoscopic visible light spectroscopy after luminal feeding.

van Dijk LJD, Harki J, van Noord D, de Vries AC, Moelker A, Verhagen HJM, Kuipers EJ, Bruno MJ.

Gastrointest Endosc. 2019 Jan;89(1):94-102. doi: 10.1016/j.gie.2018.07.024. Epub 2018 Jul 25.

PMID:
30055157
21.

Intraobserver and interobserver reliability of visible light spectroscopy during upper gastrointestinal endoscopy.

van Dijk LJD, van der Wel T, van Noord D, Moelker A, Verhagen HJM, Nieboer D, Kuipers EJ, Bruno MJ.

Expert Rev Med Devices. 2018 Aug;15(8):605-610. doi: 10.1080/17434440.2018.1496818. Epub 2018 Jul 18.

PMID:
29973094
22.

Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and meta-analysis.

Wieten E, Schreuders EH, Grobbee EJ, Nieboer D, Bramer WM, Lansdorp-Vogelaar I, Bruno MJ, Kuipers EJ, Spaander MCW.

Gut. 2019 May;68(5):873-881. doi: 10.1136/gutjnl-2017-315340. Epub 2018 Jun 22.

PMID:
29934436
23.

Natural History of Barrett's Esophagus.

Kuipers EJ, Spaander MC.

Dig Dis Sci. 2018 Aug;63(8):1997-2004. doi: 10.1007/s10620-018-5161-x. Review.

24.

Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions.

den Hollander WJ, Holster IL, den Hoed CM, Capelle LG, Tang TJ, Anten MP, Prytz-Berset I, Witteman EM, Ter Borg F, Hartog GD, Bruno MJ, Peppelenbosch MP, Lesterhuis W, Doukas M, Kuipers EJ, Spaander MCW.

Gut. 2019 Apr;68(4):585-593. doi: 10.1136/gutjnl-2017-314498. Epub 2018 Jun 6.

PMID:
29875257
25.

Effect of anticoagulants and NSAIDs on accuracy of faecal immunochemical tests (FITs) in colorectal cancer screening: a systematic review and meta-analysis.

Nieuwenburg SAV, Vuik FER, Kruip MJHA, Kuipers EJ, Spaander MCW.

Gut. 2019 May;68(5):866-872. doi: 10.1136/gutjnl-2018-316344. Epub 2018 Jun 5.

PMID:
29871970
26.

Prophylactic angiographic embolisation after endoscopic control of bleeding to high-risk peptic ulcers: a randomised controlled trial.

Lau JYW, Pittayanon R, Wong KT, Pinjaroen N, Chiu PWY, Rerknimitr R, Holster IL, Kuipers EJ, Wu KC, Au KWL, Chan FKL, Sung JJY.

Gut. 2019 May;68(5):796-803. doi: 10.1136/gutjnl-2018-316074. Epub 2018 May 25.

PMID:
29802172
27.

Personalized screening for colorectal cancer.

Kuipers EJ, Spaander MC.

Nat Rev Gastroenterol Hepatol. 2018 Jul;15(7):391-392. doi: 10.1038/s41575-018-0015-8. No abstract available.

PMID:
29713023
28.

Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018.

Sung JJ, Chiu PW, Chan FKL, Lau JY, Goh KL, Ho LH, Jung HY, Sollano JD, Gotoda T, Reddy N, Singh R, Sugano K, Wu KC, Wu CY, Bjorkman DJ, Jensen DM, Kuipers EJ, Lanas A.

Gut. 2018 Oct;67(10):1757-1768. doi: 10.1136/gutjnl-2018-316276. Epub 2018 Apr 24. Erratum in: Gut. 2019 Feb;68(2):380.

29.

Evaluation of Cancer-Associated DNA Copy Number Events in Colorectal (Advanced) Adenomas.

Carvalho B, Diosdado B, Terhaar Sive Droste JS, Bolijn AS, Komor MA, de Wit M, Bosch LJW, van Burink M, Dekker E, Kuipers EJ, Coupé VMH, van Grieken NCT, Fijneman RJA, Meijer GA.

Cancer Prev Res (Phila). 2018 Jul;11(7):403-412. doi: 10.1158/1940-6207.CAPR-17-0317. Epub 2018 Apr 23.

30.

Endoscopic screening for gastric cancer: A cost-utility analysis for countries with an intermediate gastric cancer risk.

Areia M, Spaander MC, Kuipers EJ, Dinis-Ribeiro M.

United European Gastroenterol J. 2018 Mar;6(2):192-202. doi: 10.1177/2050640617722902. Epub 2017 Jul 18.

31.

Colorectal Cancer: Cost-effectiveness of Colonoscopy versus CT Colonography Screening with Participation Rates and Costs.

van der Meulen MP, Lansdorp-Vogelaar I, Goede SL, Kuipers EJ, Dekker E, Stoker J, van Ballegooijen M.

Radiology. 2018 Jun;287(3):901-911. doi: 10.1148/radiol.2017162359. Epub 2018 Feb 27.

32.

PPIs for prevention and treatment of peptic ulcer.

Kuipers EJ.

Lancet Gastroenterol Hepatol. 2018 Apr;3(4):214-215. doi: 10.1016/S2468-1253(18)30047-5. Epub 2018 Feb 21. No abstract available.

33.

Risk of Oral and Upper Gastrointestinal Cancers in Persons With Positive Results From a Fecal Immunochemical Test in a Colorectal Cancer Screening Program.

van der Vlugt M, Grobbee EJ, Bossuyt PM, Bos ACRK, Kuipers EJ, Lansdorp-Vogelaar I, Spaander MCW, Dekker E.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1237-1243.e2. doi: 10.1016/j.cgh.2018.01.037. Epub 2018 Feb 7.

PMID:
29427732
34.

Colorectal cancer screening in Australia.

Kuipers EJ, Lansdorp-Vogelaar I.

Lancet Public Health. 2017 Jul;2(7):e304-e305. doi: 10.1016/S2468-2667(17)30121-4. Epub 2017 Jun 26. No abstract available.

35.

Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer.

Janmaat VT, Steyerberg EW, van der Gaast A, Mathijssen RH, Bruno MJ, Peppelenbosch MP, Kuipers EJ, Spaander MC.

Cochrane Database Syst Rev. 2017 Nov 28;11:CD004063. doi: 10.1002/14651858.CD004063.pub4. Review.

36.

Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists.

Houben E, Johansson S, Nagy P, Penning-van Beest FJA, Kuipers EJ, Herings RMC.

Curr Med Res Opin. 2018 Apr;34(4):577-583. doi: 10.1080/03007995.2017.1407302. Epub 2017 Nov 24.

PMID:
29149805
37.

Helicobacter pylori colonization and obesity - a Mendelian randomization study.

den Hollander WJ, Broer L, Schurmann C, Meyre D, den Hoed CM, Mayerle J, Hofman A, Homuth G, Uitterlinden AG, Lerch MM, Kuipers EJ.

Sci Rep. 2017 Oct 31;7(1):14467. doi: 10.1038/s41598-017-14106-4.

39.

Analysis of SHIP1 expression and activity in Crohn's disease patients.

Somasundaram R, Fernandes S, Deuring JJ, de Haar C, Kuipers EJ, Vogelaar L, Middleton FA, van der Woude CJ, Peppelenbosch MP, Kerr WG, Fuhler GM.

PLoS One. 2017 Aug 2;12(8):e0182308. doi: 10.1371/journal.pone.0182308. eCollection 2017.

40.

Association Between Concentrations of Hemoglobin Determined by Fecal Immunochemical Tests and Long-term Development of Advanced Colorectal Neoplasia.

Grobbee EJ, Schreuders EH, Hansen BE, Bruno MJ, Lansdorp-Vogelaar I, Spaander MCW, Kuipers EJ.

Gastroenterology. 2017 Nov;153(5):1251-1259.e2. doi: 10.1053/j.gastro.2017.07.034. Epub 2017 Jul 29.

PMID:
28760383
41.

Editorial: the risk of cancer in patients with gastric intestinal metaplasia.

Kuipers EJ.

Aliment Pharmacol Ther. 2017 Aug;46(3):374-375. doi: 10.1111/apt.14155. No abstract available.

42.

Validation of a Novel Immunoline Assay for Patient Stratification according to Virulence of the Infecting Helicobacter pylori Strain and Eradication Status.

Formichella L, Romberg L, Meyer H, Bolz C, Vieth M, Geppert M, Göttner G, Nölting C, Schepp W, Schneider A, Ulm K, Wolf P, Holster IL, Kuipers EJ, Birkner B, Soutschek E, Gerhard M.

J Immunol Res. 2017;2017:8394593. doi: 10.1155/2017/8394593. Epub 2017 May 30.

43.

Optimizing Fecal Immunochemical Testing For Colorectal Cancer Screening.

Schreuders EH, Wieten E, Kuipers EJ, Spaander MCW.

Clin Gastroenterol Hepatol. 2017 Oct;15(10):1498-1499. doi: 10.1016/j.cgh.2017.06.005. Epub 2017 Jun 8. No abstract available.

PMID:
28603050
44.

A Summary of the 2016 James W. Freston Conference of the American Gastroenterological Association: Intestinal Metaplasia in the Esophagus and Stomach: Origins, Differences, Similarities and Significance.

Spechler SJ, Merchant JL, Wang TC, Chandrasoma P, Fox JG, Genta RM, Goldenring JR, Hayakawa Y, Kuipers EJ, Lund PK, McKeon F, Mills JC, Odze RD, Peek RM Jr, Pham T, Que J, Rustgi AK, Shaheen NJ, Shivdasani RA, Souza RF, Storz P, Todisco A, Wang DH, Wright NA.

Gastroenterology. 2017 Jul;153(1):e6-e13. doi: 10.1053/j.gastro.2017.05.050. Epub 2017 Jun 3. No abstract available.

45.

Gastric Cancer as Preventable Disease.

Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, Hunt RH, Kuipers EJ, Malfertheiner P, Sugano K, Graham DY.

Clin Gastroenterol Hepatol. 2017 Dec;15(12):1833-1843. doi: 10.1016/j.cgh.2017.05.023. Epub 2017 May 19. Review.

PMID:
28532700
46.

Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015.

GBD 2015 Healthcare Access and Quality Collaborators. Electronic address: cjlm@uw.edu; GBD 2015 Healthcare Access and Quality Collaborators.

Lancet. 2017 Jul 15;390(10091):231-266. doi: 10.1016/S0140-6736(17)30818-8. Epub 2017 May 18.

47.

Do Men and Women Need to Be Screened Differently with Fecal Immunochemical Testing? A Cost-Effectiveness Analysis.

Meulen MPV, Kapidzic A, Leerdam MEV, van der Steen A, Kuipers EJ, Spaander MCW, de Koning HJ, Hol L, Lansdorp-Vogelaar I.

Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1328-1336. doi: 10.1158/1055-9965.EPI-16-0786. Epub 2017 May 17.

48.

Fecal immunochemical test-based colorectal cancer screening: The gender dilemma.

Grobbee EJ, Wieten E, Hansen BE, Stoop EM, de Wijkerslooth TR, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Kuipers EJ, Spaander MC.

United European Gastroenterol J. 2017 Apr;5(3):448-454. doi: 10.1177/2050640616659998. Epub 2016 Jul 14.

49.

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative.

Kaminski MF, Thomas-Gibson S, Bugajski M, Bretthauer M, Rees CJ, Dekker E, Hoff G, Jover R, Suchanek S, Ferlitsch M, Anderson J, Roesch T, Hultcranz R, Racz I, Kuipers EJ, Garborg K, East JE, Rupinski M, Seip B, Bennett C, Senore C, Minozzi S, Bisschops R, Domagk D, Valori R, Spada C, Hassan C, Dinis-Ribeiro M, Rutter MD.

United European Gastroenterol J. 2017 Apr;5(3):309-334. doi: 10.1177/2050640617700014. Epub 2017 Mar 16. Review.

50.

Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.

van der Vlugt M, Grobbee EJ, Bossuyt PMM, Bos A, Bongers E, Spijker W, Kuipers EJ, Lansdorp-Vogelaar I, Spaander MCW, Dekker E.

Gastroenterology. 2017 Aug;153(2):439-447.e2. doi: 10.1053/j.gastro.2017.05.004. Epub 2017 May 5.

PMID:
28483499

Supplemental Content

Loading ...
Support Center